Jordan B. King

2.3k total citations
73 papers, 1.2k citations indexed

About

Jordan B. King is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Jordan B. King has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 13 papers in Economics and Econometrics. Recurrent topics in Jordan B. King's work include Blood Pressure and Hypertension Studies (31 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Jordan B. King is often cited by papers focused on Blood Pressure and Hypertension Studies (31 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Jordan B. King collaborates with scholars based in United States, Canada and United Kingdom. Jordan B. King's co-authors include Adam P. Bress, Brandon K. Bellows, Rashmee U. Shah, Catherine G. Derington, Richard E. Nelson, Nassir Marrouche, Andrew E. Moran, Brent D. Wilson, Frederick T. Han and Eugene Kholmovski and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Jordan B. King

72 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jordan B. King

Since Specialization

Citations

This map shows the geographic impact of Jordan B. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan B. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan B. King more than expected).

Fields of papers citing papers by Jordan B. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordan B. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan B. King. The network helps show where Jordan B. King may publish in the future.

Co-authorship network of co-authors of Jordan B. King

This figure shows the co-authorship network connecting the top 25 collaborators of Jordan B. King. A scholar is included among the top collaborators of Jordan B. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordan B. King. Jordan B. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia 2025 ·The Journals of Gerontology Series A ·Catherine G. Derington, (unknown), Daniel O. Scharfstein, Ryan M. Andrews, Tom Greene, Yizhe Xu, Jordan B. King, Mark A. Supiano, Joshua A. Sonnen, Jeff D. Williamson, Nicholas M. Pajewski, Jeremy J. Pruzin, Jordana B. Cohen, Adam P. Bress	2
2	Association Between Self‐Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial) 2024 ·Journal of the American Heart Association ·Joshua A. Jacobs, Catherine G. Derington, Alexander R. Zheutlin, Jordan B. King, Jordana B. Cohen, John D. Bucheit, Ian M. Kronish, (unknown), Donald E. Morisky, Tom Greene, Adam P. Bress	3
3	Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study 2024 ·Journal of the American Heart Association ·(unknown), (unknown), Andrew E. Moran, Yiyi Zhang, Jordana B. Cohen, Adam P. Bress, James P Sheppard, Jordan B. King, Catherine G. Derington, William S. Weintraub, Ian M. Kronish, Steven Shea, Brandon K. Bellows	5
4	Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021 2024 ·Hypertension ·Joshua A. Jacobs, Anthony Rodgers, Brandon K. Bellows, Inmaculada Hernandez, Nelson Wang, Catherine G. Derington, Jordan B. King, Alexander R. Zheutlin, Paul K. Whelton, Brent M. Egan, William C. Cushman, Adam P. Bress	2
5	Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US 2023 ·JAMA Cardiology ·Joshua A. Jacobs, (unknown), Alexander R. Zheutlin, Catherine G. Derington, Utibe R. Essien, Ann Marie Návar, Inmaculada Hernandez, Donald M. Lloyd‐Jones, Jordan B. King, Shreya Rao, Jennifer S. Herrick, Adam P. Bress, Ambarish Pandey	36
6	Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial 2023 ·Hypertension ·Jordan B. King, Catherine G. Derington, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, Molly B. Conroy, William C. Cushman, Adam P. Bress	5
7	Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020 2023 ·Journal of the American Heart Association ·Catherine G. Derington, Adam P. Bress, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, (unknown), Molly B. Conroy, William C. Cushman, Jordan B. King	14
8	New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT 2023 ·Journal of the American Heart Association ·Jordan B. King, (unknown), Catherine G. Derington, Zachary A. Marcum, Daniel O. Scharfstein, Tom Greene, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, Adam P. Bress, Jordana B. Cohen	4
9	Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation 2023 ·JAMA Network Open ·Catherine G. Derington, Glenn K. Goodrich, Stanley Xu, Nathan P. Clark, Kristi Reynolds, Jaejin An, Daniel M. Witt, David H. Smith, Maureen O’Keeffe‐Rosetti, (unknown), P. Michael Ho, T. Craig Cheetham, Angela C. Comer, Jordan B. King	4
10	Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial 2022 ·Hypertension ·Catherine G. Derington, Adam P. Bress, Andrew E. Moran, William S. Weintraub, Jennifer S. Herrick, William C. Cushman, Ian M. Kronish, Barry M. Stults, Daichi Shimbo, Paul Muntner, Tom Greene, Jeffrey T. Bates, Tara I. Chang, Lois Katz, Shakaib U. Rehman, Christianne L. Roumie, Leonardo Tamariz, Jordan B. King	6
11	Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction 2021 ·Journal of clinical lipidology ·(unknown), (unknown), Adam P. Bress, Catherine G. Derington, Jordan B. King, Ying Wen, Ligong Chen, Vera Bittner, Todd M. Brown, Keri L. Monda, Katherine E. Mues, Robert S. Rosenson, Elizabeth A. Jackson, Paul Muntner, Lisandro D. Colantonio	18
12	Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018 2021 ·American Heart Journal ·Alexander R. Zheutlin, Catherine G. Derington, Jordan B. King, (unknown), Jennifer S. Herrick, Dave L. Dixon, Jordana B. Cohen, Daichi Shimbo, Ian M. Kronish, Joseph J. Saseen, Paul Muntner, Andrew E. Moran, Adam P. Bress	3
13	The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring 2020 ·Journal of Thrombosis and Thrombolysis ·Aubrey E. Jones, Jordan B. King, Kibum Kim, Daniel M. Witt	7
14	Thyroid Stimulating Hormone Stability in Patients Prescribed Synthetic or Desiccated Thyroid Products: A Retrospective Study 2020 ·The Annals of Family Medicine ·(unknown), (unknown), Jordan B. King, (unknown), Deanna Kurz, Jessica L. Milchak	9
15	COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN US REDUCE-IT PATIENTS 2020 ·Journal of the American College of Cardiology ·William Weintraub, Deepak L. Bhatt, Zugui Zhang, Cheng Zhang, (unknown), William E. Boden, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Jordan B. King, Adam P. Bress, Terry A. Jacobson, Jean‐Claude Tardif, Christie M. Ballantyne, Paul Kolm	12
16	Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation 2017 ·Journal of the American College of Cardiology ·Jordan B. King, Peyman N. Azadani, Promporn Suksaranjit, Adam P. Bress, Daniel M. Witt, Frederick T. Han, Mihail G. Chelu, Michelle Silver, Joseph Biskupiak, Brent D. Wilson, Alan Morris, Eugene Kholmovski, Nassir Marrouche	141
17	Partnering with consumers to develop and evaluate a Vietnamese Dementia Talking-Book to support low health literacy: a qualitative study incorporating codesign and participatory action research 2016 ·BMJ Open ·Dianne Goeman, (unknown), Jordan B. King, (unknown), (unknown), Sebastian Koch	12
18	Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction 2016 ·JACC Heart Failure ·Jordan B. King, Rashmee U. Shah, Adam P. Bress, Richard E. Nelson, Brandon K. Bellows	107
19	A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain 2015 ·Therapeutics and Clinical Risk Management ·Brandon K. Bellows, Jordan B. King, (unknown)	11
20	The first 100 patients in the Valkenberg Psychogeriatric Assessment Unit. 1978 ·PubMed ·(unknown), (unknown), L. S. Gillis, Jordan B. King	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact